{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T05:32:05Z","timestamp":1773811925208,"version":"3.50.1"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,1]]},"abstract":"<jats:sec>\n            <jats:title>Objective:<\/jats:title>\n            <jats:p>The aims of this study were to assess symptoms of depression, anxiety, and stress and associated sociodemographic factors among people living with chronic hepatitis C virus (HCV) infection with a history of injecting drug use and to assess the association between symptoms of depression, anxiety, or stress and HCV treatment intent, specialist assessment, or treatment uptake.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>The Enhancing Treatment for Hepatitis C in Opioid Substitution Settings was an observational cohort study evaluating the provision of HCV assessment and treatment among people with chronic HCV and a history of injecting drug use, recruited from 9 community health centers and opioid substitution therapy (OST) clinics (New South Wales, Australia). Symptoms were assessed using the Depression Anxiety Stress Scales (DASS-21). Analyses were performed using logistic regression.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Among 415 participants (mean age 41 years, 71% male), 47%, 52%, and 36% demonstrated moderate to extremely severe symptoms of depression, anxiety, and stress, respectively. In adjusted analyses, depression symptoms were associated with recent injecting drug use [adjusted odds ratio (aOR) 1.63, 95% confidence interval (CI) 1.07\u20132.49), whereas stress symptoms were associated with unemployment (aOR 2.99, 95% CI 1.09\u20138.15) and not living with a spouse or other relatives\/friends (aOR 1.55, 95% CI 1.01\u20132.39). Symptoms of depression, anxiety, or stress or having a history of treated mental illness were not independently associated with HCV treatment intent, specialist assessment, or treatment uptake.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Findings suggest a need for improved interventions and care regarding mental health among people living with chronic HCV with a history of injecting drug use, but suggest that symptoms of depression, anxiety, and stress should not be immediate contraindications to HCV assessment and treatment.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/adm.0000000000000261","type":"journal-article","created":{"date-parts":[[2016,10,22]],"date-time":"2016-10-22T11:13:00Z","timestamp":1477134780000},"page":"10-18","source":"Crossref","is-referenced-by-count":11,"title":["Depression, Anxiety, and Stress Among People With Chronic Hepatitis C Virus Infection and a History of Injecting Drug Use in New South Wales, Australia"],"prefix":"10.1097","volume":"11","author":[{"given":"Emmanuel","family":"Fortier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Alavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Bruneau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Micallef","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacinta","family":"Perram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjeev","family":"Sockalingam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian J.","family":"Dunlop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annie C.","family":"Balcomb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolyn A.","family":"Day","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla","family":"Treloar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicky","family":"Bath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul S.","family":"Haber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory J.","family":"Dore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Grebely","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230828","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1111\/j.1440-1746.2011.07035.x","article-title":"Effect of pegylated interferon-alpha-2a treatment on mental health during recent hepatitis C virus infection","volume":"27","author":"Alavi","year":"2012","journal-title":"J Gastroenterol Hepatol"},{"issue":"(suppl 2)","key":"R2-20230828","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1093\/cid\/cit305","article-title":"Assessment and treatment of hepatitis C virus infection among people who inject drugs in the opioid substitution setting: ETHOS study","volume":"57","author":"Alavi","year":"2013","journal-title":"Clin Infect Dis"},{"key":"R3-20230828","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1111\/jvh.12415","article-title":"Effect of treatment willingness on specialist assessment and treatment uptake for hepatitis C virus infection among people who use drugs: the ETHOS study","volume":"22","author":"Alavi","year":"2015","journal-title":"J Viral Hepat"},{"key":"R4-20230828","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.drugpo.2015.05.003","article-title":"Injecting risk behaviours following treatment for hepatitis C virus infection among people who inject drugs: The Australian Trial in Acute Hepatitis C","volume":"26","author":"Alavi","year":"2015","journal-title":"Int J Drug Policy"},{"key":"R5-20230828","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1111\/j.1478-3231.2010.02235.x","article-title":"Comorbidities associated with the increasing burden of hepatitis C infection","volume":"30","author":"Basseri","year":"2010","journal-title":"Liver Int"},{"key":"R6-20230828","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.genhosppsych.2007.08.014","article-title":"High frequency of unrecognized mental disorders in HCV-infected patients","volume":"30","author":"Batista-Neves","year":"2008","journal-title":"Gen Hosp Psychiatry"},{"key":"R7-20230828","doi-asserted-by":"crossref","first-page":"4665","DOI":"10.3748\/wjg.v12.i29.4665","article-title":"Mental and physical symptoms associated with lower social support for patients with hepatitis C","volume":"12","author":"Blasiole","year":"2006","journal-title":"World J Gastroenterol"},{"key":"R8-20230828","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/hep.27422","article-title":"Predictors of poor mental and physical health status among patients with chronic hepatitis C infection: the Chronic Hepatitis Cohort Study (CHeCS)","volume":"61","author":"Boscarino","year":"2015","journal-title":"Hepatology"},{"key":"R9-20230828","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1080\/09540120412331291733","article-title":"Quality of life, depression and fatigue among persons co-infected with HIV and hepatitis C: outcomes from a population-based cohort","volume":"17","author":"Braitstein","year":"2005","journal-title":"AIDS Care"},{"key":"R10-20230828","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1001\/archinte.158.16.1789","article-title":"The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test","volume":"158","author":"Bush","year":"1998","journal-title":"Archives of Internal Medicine"},{"key":"R11-20230828","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1365-2893.2005.00681.x","article-title":"Comparison of hepatitis C treatment patterns in patients with and without psychiatric and\/or substance use disorders","volume":"13","author":"Chainuvati","year":"2006","journal-title":"J Viral Hepat"},{"key":"R12-20230828","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1742-9544.2010.00003.x","article-title":"Percentile Norms and Accompanying Interval Estimates from an Australian General Adult Population Sample for Self-Report Mood Scales (BAI, BDI, CRSD, CES-D, DASS, DASS-21, STAI-X, STAI-Y, SRDS, and SRAS)","volume":"46","author":"Crawford","year":"2011","journal-title":"Aust Psychol"},{"key":"R13-20230828","doi-asserted-by":"crossref","first-page":"360","DOI":"10.2975\/27.2004.360.374","article-title":"A review of treatments for people with severe mental illnesses and co-occurring substance use disorders","volume":"27","author":"Drake","year":"2004","journal-title":"Psychiatr Rehabil J"},{"key":"R14-20230828","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1038\/ajg.2011.219","article-title":"A randomized controlled trial of an integrated care intervention to increase eligibility for chronic hepatitis C treatment","volume":"106","author":"Evon","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"R15-20230828","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1111\/j.1365-2036.2010.04460.x","article-title":"Barriers to accessing care in patients with chronic hepatitis C: the impact of depression","volume":"32","author":"Evon","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"R16-20230828","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.drugpo.2015.06.001","article-title":"The effect of social functioning and living arrangement on treatment intent, specialist assessment and treatment uptake for hepatitis C virus infection among people with a history of injecting drug use: The ETHOS study","volume":"26","author":"Fortier","year":"2015","journal-title":"Int J Drug Policy"},{"key":"R17-20230828","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.genhosppsych.2005.06.006","article-title":"Depression and anxiety in patients with hepatitis C: prevalence, detection rates and risk factors","volume":"27","author":"Golden","year":"2005","journal-title":"Gen Hosp Psychiatry"},{"key":"R18-20230828","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1001\/archpsyc.61.8.807","article-title":"Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions","volume":"61","author":"Grant","year":"2004","journal-title":"Arch Gen Psychiatry"},{"issue":"(suppl 1)","key":"R19-20230828","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1093\/infdis\/jis928","article-title":"Breaking down the barriers to hepatitis C virus (HCV) treatment among individuals with HCV\/HIV coinfection: action required at the system, provider, and patient levels","volume":"207","author":"Grebely","year":"2013","journal-title":"J Infect Dis"},{"key":"R20-20230828","first-page":"119","article-title":"Does depression symptomatology affect medication compliance during the first weeks of anti-HCV therapy in intravenous drug users?","volume":"38","author":"Guadagnino","year":"2006","journal-title":"Dig Liver Dis"},{"key":"R21-20230828","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/S0140-6736(09)61036-9","article-title":"Management of injecting drug users admitted to hospital","volume":"374","author":"Haber","year":"2009","journal-title":"Lancet"},{"key":"R22-20230828","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nrgastro.2013.107","article-title":"Epidemiology and natural history of HCV infection","volume":"10","author":"Hajarizadeh","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"(pt 2)","key":"R23-20230828","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1348\/014466505X29657","article-title":"The short-form version of the Depression Anxiety Stress Scales (DASS-21): construct validity and normative data in a large non-clinical sample","volume":"44","author":"Henry","year":"2005","journal-title":"Br J Clin Psychol"},{"issue":"10","key":"R24-20230828","article-title":"Psychosocial interventions for people with both severe mental illness and substance misuse","author":"Hunt","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"R25-20230828","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1111\/j.1572-0241.2006.00731.x","article-title":"Integrated psychiatric\/medical care in a chronic hepatitis C clinic: effect on antiviral treatment evaluation and outcomes","volume":"101","author":"Knott","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"R26-20230828","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/ajg.2010.430","article-title":"Importance of patient, provider, and facility predictors of hepatitis C virus treatment in veterans: a national study","volume":"106","author":"Kramer","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"R27-20230828","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.psym.2012.09.005","article-title":"Association of chronic liver disease with depression: a population-based study","volume":"54","author":"Lee","year":"2013","journal-title":"Psychosomatics"},{"key":"R28-20230828","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.drugalcdep.2011.12.012","article-title":"Prevalence of psychiatric disorders among young injection drug users","volume":"124","author":"Mackesy-Amiti","year":"2012","journal-title":"Drug Alcohol Depend"},{"key":"R29-20230828","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1037\/a0036390","article-title":"Psychiatric correlates of injection risk behavior among young people who inject drugs","volume":"28","author":"Mackesy-Amiti","year":"2014","journal-title":"Psychol Addict Behav"},{"key":"R30-20230828","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.drugpo.2015.04.012","article-title":"Beyond viral response: a prospective evaluation of a community-based, multi-disciplinary, peer-driven model of HCV treatment and support","volume":"26","author":"Mason","year":"2015","journal-title":"Int J Drug Policy"},{"key":"R31-20230828","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/1471-2334-14-203","article-title":"Factors influencing adherence in Hepatitis-C infected patients: a systematic review","volume":"14","author":"Mathes","year":"2014","journal-title":"BMC Infect Dis"},{"key":"R32-20230828","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1155\/2013\/515636","article-title":"Treatment of chronic hepatitis C infection among current and former injection drug users within a multidisciplinary treatment model at a community health centre","volume":"27","author":"Newman","year":"2013","journal-title":"Can J Gastroenterol"},{"key":"R33-20230828","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1089\/apc.2009.0153","article-title":"Factors that influence an HIV coinfected patient's decision to start hepatitis C treatment","volume":"23","author":"Osilla","year":"2009","journal-title":"AIDS Patient Care STDS"},{"key":"R34-20230828","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1176\/ps.2010.61.9.885","article-title":"Assessing the STIRR model of best practices for blood-borne infections of clients with severe mental illness","volume":"61","author":"Rosenberg","year":"2010","journal-title":"Psychiatr Serv"},{"issue":"(suppl 2)","key":"R35-20230828","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.1093\/cid\/cit266","article-title":"Management of mental health problems prior to and during treatment of hepatitis C virus infection in patients with drug addiction","volume":"57","author":"Schaefer","year":"2013","journal-title":"Clin Infect Dis"},{"key":"R36-20230828","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1053\/jhep.2003.50031","article-title":"Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups","volume":"37","author":"Schaefer","year":"2003","journal-title":"Hepatology"},{"key":"R37-20230828","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/MCG.0b013e3182008ee1","article-title":"Diagnosis of depression in former injection drug users with chronic hepatitis C","volume":"45","author":"Scott","year":"2011","journal-title":"J Clin Gastroenterol"},{"key":"R38-20230828","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1176\/appi.ajp.2015.14081041","article-title":"Psychiatric care during hepatitis C treatment: the changing role of psychiatrists in the era of direct-acting antivirals","volume":"172","author":"Sockalingam","year":"2015","journal-title":"Am J Psychiatry"},{"key":"R39-20230828","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/dar.12257","article-title":"Multiply disadvantaged: Health and service utilisation factors faced by homeless injecting drug consumers in Australia","volume":"34","author":"Whittaker","year":"2015","journal-title":"Drug Alcohol Rev"},{"key":"R40-20230828","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/j.1365-2893.2010.01361.x","article-title":"Tobacco and other factors have a negative impact on quality of life in hepatitis C patients","volume":"18","author":"Yamini","year":"2011","journal-title":"J Viral Hepat"},{"key":"R41-20230828","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1176\/appi.psy.42.5.411","article-title":"Psychiatric comorbidity among hepatitis C: positive patients","volume":"42","author":"Yovtcheva","year":"2001","journal-title":"Psychosomatics"}],"container-title":["Journal of Addiction Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/01271255-201702000-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T23:00:21Z","timestamp":1693263621000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01271255-201702000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/adm.0000000000000261","relation":{},"ISSN":["1932-0620","1935-3227"],"issn-type":[{"value":"1932-0620","type":"print"},{"value":"1935-3227","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1]]}}}